Loading...
•
Mar 31, 2024
Surgery Partners Q1 2024 Earnings Report
Reported strong growth in Adjusted EBITDA and revenue, exceeding expectations, driven by focus on clinical quality, operational execution, and strategic physician recruitment and acquisitions.
Key Takeaways
Surgery Partners reported a 7.7% increase in revenue to $717.4 million and an Adjusted EBITDA of $97.5 million, representing an 8.2% growth compared to the prior year period. The company raised its full-year guidance to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDA.
Revenues increased 7.7% to $717.4 million compared to the prior year period.
Same-facility revenues increased 10.2%.
Adjusted EBITDA was $97.5 million, representing 8.2% growth compared to the prior year period.
Full year guidance raised to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDA.
Forward Guidance
The Company raised its outlook for 2024 revenues to be at least $3.05 billion and projects 2024 Adjusted EBITDA to be at least $505 million.
Positive Outlook
- Revenue to be at least $3.05 billion
- Adjusted EBITDA to be at least $505 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...